title: Removal of access to alemtuzumab for patients with aggressive multiple sclerosis.
authors: Alan J
authors: AJ
authors: Thompson
authors: Gavin
authors: G
authors: Giovannoni
mesh_terms: D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D006801:Humans; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D056737:Safety-Based Drug Withdrawals; D006113:United Kingdom
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000074323:Alemtuzumab